Dellehunt Rachel E., Manna Biagio
Cape Fear Valley Medical Center, CUSOM
RWJUH/Barnabas Health System
Aortofemoral bypass surgery is a procedure utilized commonly for the treatment of aortoiliac occlusive disease, sometimes referred to as Leriche syndrome. Aortoiliac occlusive disease can contribute to lower extremity ischemic symptoms necessitating intervention. Symptoms of patients with aortoiliac occlusive disease may include claudication, rest pain of the lower extremities, or ischemic ulcer formation on lower extremities due to inadequate blood flow. However, patients may also be asymptomatic. An ankle-brachial index is the most widely used test to determine peripheral arterial disease initially. Aortofemoral bypass surgery has aided in the management of aortoiliac occlusive disease dating back to the early 1950s. More recently, revascularization with endovascular interventions has supplanted the aortofemoral bypass surgery as first-line therapy. However, in cases where endovascular techniques are unsuccessful or inappropriate, aortobifemoral bypass still plays an important role and can even be considered the gold standard for long term patency. This will discuss the relevant anatomy, indications, contraindications, as well as some important technique considerations.
主-股动脉搭桥手术是一种常用于治疗主-髂动脉闭塞性疾病(有时称为勒里什综合征)的手术。主-髂动脉闭塞性疾病可导致下肢缺血症状,需要进行干预。主-髂动脉闭塞性疾病患者的症状可能包括间歇性跛行、下肢静息痛或由于血流不足导致下肢出现缺血性溃疡。然而,患者也可能没有症状。踝肱指数是最初用于确定外周动脉疾病最广泛使用的检查。主-股动脉搭桥手术自20世纪50年代初就已用于主-髂动脉闭塞性疾病的治疗。最近,血管内介入再血管化已取代主-股动脉搭桥手术成为一线治疗方法。然而,在血管内技术不成功或不适用的情况下,主-双股动脉搭桥仍发挥着重要作用,甚至可被视为长期通畅的金标准。本文将讨论相关解剖结构、适应证、禁忌证以及一些重要的技术要点。